Torrey Pines Investment LLC
Specialty life-science investment firm (founded 2012) based in San Diego, CA. Provides early- and development-stage capital and accelerator support for biotech and diagnostics companies, and assists portfolio companies with product and corporate development including drug discovery, non-clinical and clinical studies, manufacturing/CMC and regulatory affairs, business development and exit activities.
Torrey Pines Investment LLC
San Diego, California, United States, North America
Services
Early-stage venture investment
Equity investments and coordination of funding rounds for early to development-stage life-science companies.
Accelerator and incubation services
Programmatic incubation, technical mentorship and milestone-driven acceleration to advance discovery platforms toward lead selection and clinical candidate stages; includes portfolio program and project management.
Corporate and product development support
Advisory support across drug discovery, non-clinical and clinical development, CMC and regulatory planning to ready assets for partnering or clinical progression.
Business development and partnering advisory
Support BD&L activities including partner identification, licensing discussions and M&A facilitation.
Early-stage venture investment
Equity investments and coordination of funding rounds for early to development-stage life-science companies.
Accelerator and incubation services
Programmatic incubation, technical mentorship and milestone-driven acceleration to advance discovery platforms toward lead selection and clinical candidate stages; includes portfolio program and project management.
Corporate and product development support
Advisory support across drug discovery, non-clinical and clinical development, CMC and regulatory planning to ready assets for partnering or clinical progression.
Business development and partnering advisory
Support BD&L activities including partner identification, licensing discussions and M&A facilitation.
Expertise Areas
- Life-science venture investing
- Early-stage accelerator and incubation management
- Clinical development and trial management
- Drug discovery and preclinical development
Key Technologies
- High-density microarray patch vaccine delivery
- Dry-coating thermostable vaccine formulations
- Stabilized engineered protein antigens with multiple stabilizing mutations
- mRNA vaccine platforms